Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
PaperCitations, authors & open-access status
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 82 citations, 2023 year and bronze oa status.
82
Citations
2023
Year
bronze
OA Status